Clinical Trials Logo

Femoral Acetabular Impingement clinical trials

View clinical trials related to Femoral Acetabular Impingement.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04951180 Recruiting - Clinical trials for Femoral Acetabular Impingement

Arthroscopic Treatment for Femoral Acetabular Impingement Syndrome With Gluteus Medius Lesions.

Start date: May 1, 2021
Phase:
Study type: Observational

To evaluate the prognosis of femoral acetabular impingement syndrome (FAIS) patients with gluteus medius lesions after hip arthroscopy.

NCT ID: NCT04113759 Recruiting - Clinical trials for Labral Tear, Glenoid

Blood Flow Restriction Following Hip Arthroscopy

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

This study will be a prospective randomized, double-blinded, placebo-controlled trial of patients undergoing primary hip arthroscopy for FAIS and/or labral pathology. All patients who sign the consent form will be enrolled in the study and randomized to one of the two treatment arms. Follow-up will take place at 1-month, 3-months, 6-months, and 1-year.

NCT ID: NCT04094701 Recruiting - Pain Clinical Trials

Hip Arthroscopy Postoperative Opioid Demands

Start date: October 21, 2020
Phase: N/A
Study type: Interventional

This study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one of the two treatment arms. The intervention group will receive 5 Norco pills, gabapentin (30 mg, once daily for 10 days following surgery), and Tylenol (1000 mg, three times daily for 10 days following surgery) while the control will receive the standard at our practice of 30 Norco pills.